Novartis Investigative Site

Bristol, Avon BS2 8ED

1 studies enrolling now · 3 studies all time

What they study most

Metastatic Renal Cell Carcinoma, Oligometastatic Prostate Cancer (OMPC), Renal Cell Carcinoma

Studies at this site

• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. — Recruiting now
• Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma — Completed
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed